Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer

NCT03131037 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: CAN-2409 + valacyclovir

Sponsor

Candel Therapeutics, Inc.

Collaborators

[object Object]